HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alejandro B Balazs Selected Research

BNT162 Vaccine

8/2022Significant Reduction in Vaccine-Induced Antibody Levels and Neutralization Activity Among Healthcare Workers and Nursing Home Residents 6 Months Following Coronavirus Disease 2019 BNT162b2 mRNA Vaccination.
1/2022Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study.
1/2022Comparative Immunogenicity and Effectiveness of mRNA-1273, BNT162b2, and Ad26.COV2.S COVID-19 Vaccines.
11/2021Does a lack of vaccine side effects correlate with reduced BNT162b2 mRNA vaccine response among healthcare workers and nursing home residents?
10/2021Comparative immunogenicity and effectiveness of mRNA-1273, BNT162b2 and Ad26.COV2.S COVID-19 vaccines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alejandro B Balazs Research Topics

Disease

21Infections
08/2022 - 08/2011
7COVID-19
08/2022 - 10/2020
4HIV Infections (HIV Infection)
09/2019 - 08/2011
3Neoplasms (Cancer)
10/2022 - 01/2022
3Communicable Diseases (Infectious Diseases)
01/2022 - 08/2015
3Human Influenza (Influenza)
01/2020 - 07/2013
1Persistent Infection
01/2021
1Lymphopenia (Lymphocytopenia)
01/2021
1Malaria
01/2021
1Virus Diseases (Viral Diseases)
01/2020
1Vesicular Stomatitis
01/2020
1Neurodegenerative Diseases (Neurodegenerative Disease)
08/2015
1Disease Progression
09/2014
1Myeloid Leukemia (Leukemia, Myelocytic)
08/2010
1Myeloproliferative Disorders (Myeloproliferative Disorder)
08/2010
1Aneuploidy (Aneuploid)
04/2008

Drug/Important Bio-Agent (IBA)

15VaccinesIBA
08/2022 - 03/2014
8AntibodiesIBA
01/2022 - 08/2014
8Broadly Neutralizing AntibodiesIBA
01/2022 - 01/2013
5BNT162 VaccineIBA
08/2022 - 10/2021
5Proteins (Proteins, Gene)FDA Link
01/2022 - 08/2014
4Neutralizing AntibodiesIBA
08/2022 - 09/2014
3COVID-19 VaccinesIBA
10/2022 - 01/2022
3Messenger RNA (mRNA)IBA
08/2022 - 11/2021
3Glycoproteins (Glycoprotein)IBA
01/2022 - 01/2020
3AIDS VaccinesIBA
01/2020 - 01/2017
2Monoclonal AntibodiesIBA
01/2021 - 08/2015
12019-nCoV Vaccine mRNA-1273IBA
01/2022
1Interferon Type IIBA
01/2022
1Ad26COVS1IBA
01/2022
1Immunoglobulin A (IgA)IBA
01/2022
1CIS43LSIBA
01/2021
1EpitopesIBA
01/2021
1Nucleic AcidsIBA
01/2021
1Interleukin-6 (Interleukin 6)IBA
01/2021
1CytokinesIBA
01/2021
1Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine AmidaseIBA
01/2020
1Polysaccharides (Glycans)IBA
01/2020
1Indicators and Reagents (Reagents)IBA
01/2020
1AntigensIBA
01/2020
1HIV AntibodiesIBA
09/2019
1Immunoglobulins (Immunoglobulin)IBA
12/2018
1Membrane Proteins (Integral Membrane Proteins)IBA
08/2014
1Pharmaceutical PreparationsIBA
08/2011
1Tenofovir (Viread)FDA Link
08/2011
1efavirenz (Sustiva)FDA Link
08/2011
1MicroRNAs (MicroRNA)IBA
08/2010
1Small Interfering RNA (siRNA)IBA
04/2008

Therapy/Procedure

3Therapeutics
12/2018 - 08/2011
1Home Nursing (Nursing, Home)
08/2022
1Radiotherapy
01/2022
1Long-Term Care
11/2021
1Aftercare (After-Treatment)
08/2015